Temporal trends in lipid testing among children and adolescents

A population based study

Swetha Sriram, Jennifer St. Sauver, Debra J. Jacobson, Chun Fan, Brian A Lynch, Valeria Cristiani, Iftikhar Jan Kullo, Aida N. Lteif, Seema Kumar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Unfavorable lipid levels during childhood are associated with subsequent development of atherosclerotic cardiovascular disease. The American Academy of Pediatrics and National Heart, Lung and Blood Institute in 2011 recommended universal lipid screening for children between ages 9–11 years and between ages 17–21 years. The objective of the study was to determine temporal trends in lipid testing among children and young adults in a mid-western population. The Rochester Epidemiology Project database was used to identify lipid testing in ages 2–21 years (n = 51,176) in the Olmsted County population from January 1, 2008 through December 31, 2014. Generalized estimating equations with Poisson distribution were used to test for temporal trends in lipid testing across the age groups. There was modest increase in lipid testing in children in the age groups, 9–11 years and 17–21 years (1.5% in 2008 to 2.2% in 2014, P < 0.001 and 4.4% in 2008 to 4.6% in 2014, P = 0.02, respectively). There was a significant decrease in proportion of 17–21 year olds with elevated total cholesterol (16.2% in 2008 to 11.6% in 2014; P = 0.01) and non-high density lipoprotein cholesterol (22.6% in 2008 to 12.6% in 2014; P < 0.001). In this population-based study, rates of lipid testing increased minimally only in the last six years. Further longitudinal studies are warranted to improve guideline dissemination and address attitudes, practices and barriers to lipid testing in children and young adults.

Original languageEnglish (US)
Pages (from-to)267-272
Number of pages6
JournalPreventive Medicine Reports
Volume8
DOIs
StatePublished - Dec 1 2017

Fingerprint

Lipids
Population
Young Adult
Age Groups
Poisson Distribution
National Heart, Lung, and Blood Institute (U.S.)
Hypercholesterolemia
Longitudinal Studies
Epidemiology
Cardiovascular Diseases
Databases
Guidelines
Pediatrics

Keywords

  • Children
  • Dyslipidemia
  • Hypercholesterolemia
  • Lipids
  • Screening

ASJC Scopus subject areas

  • Health Informatics
  • Public Health, Environmental and Occupational Health

Cite this

Temporal trends in lipid testing among children and adolescents : A population based study. / Sriram, Swetha; St. Sauver, Jennifer; Jacobson, Debra J.; Fan, Chun; Lynch, Brian A; Cristiani, Valeria; Kullo, Iftikhar Jan; Lteif, Aida N.; Kumar, Seema.

In: Preventive Medicine Reports, Vol. 8, 01.12.2017, p. 267-272.

Research output: Contribution to journalArticle

Sriram, Swetha ; St. Sauver, Jennifer ; Jacobson, Debra J. ; Fan, Chun ; Lynch, Brian A ; Cristiani, Valeria ; Kullo, Iftikhar Jan ; Lteif, Aida N. ; Kumar, Seema. / Temporal trends in lipid testing among children and adolescents : A population based study. In: Preventive Medicine Reports. 2017 ; Vol. 8. pp. 267-272.
@article{3846ce7b12c84efda7e45832e3e6bff7,
title = "Temporal trends in lipid testing among children and adolescents: A population based study",
abstract = "Unfavorable lipid levels during childhood are associated with subsequent development of atherosclerotic cardiovascular disease. The American Academy of Pediatrics and National Heart, Lung and Blood Institute in 2011 recommended universal lipid screening for children between ages 9–11 years and between ages 17–21 years. The objective of the study was to determine temporal trends in lipid testing among children and young adults in a mid-western population. The Rochester Epidemiology Project database was used to identify lipid testing in ages 2–21 years (n = 51,176) in the Olmsted County population from January 1, 2008 through December 31, 2014. Generalized estimating equations with Poisson distribution were used to test for temporal trends in lipid testing across the age groups. There was modest increase in lipid testing in children in the age groups, 9–11 years and 17–21 years (1.5{\%} in 2008 to 2.2{\%} in 2014, P < 0.001 and 4.4{\%} in 2008 to 4.6{\%} in 2014, P = 0.02, respectively). There was a significant decrease in proportion of 17–21 year olds with elevated total cholesterol (16.2{\%} in 2008 to 11.6{\%} in 2014; P = 0.01) and non-high density lipoprotein cholesterol (22.6{\%} in 2008 to 12.6{\%} in 2014; P < 0.001). In this population-based study, rates of lipid testing increased minimally only in the last six years. Further longitudinal studies are warranted to improve guideline dissemination and address attitudes, practices and barriers to lipid testing in children and young adults.",
keywords = "Children, Dyslipidemia, Hypercholesterolemia, Lipids, Screening",
author = "Swetha Sriram and {St. Sauver}, Jennifer and Jacobson, {Debra J.} and Chun Fan and Lynch, {Brian A} and Valeria Cristiani and Kullo, {Iftikhar Jan} and Lteif, {Aida N.} and Seema Kumar",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.pmedr.2017.11.001",
language = "English (US)",
volume = "8",
pages = "267--272",
journal = "Preventive Medicine Reports",
issn = "2211-3355",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Temporal trends in lipid testing among children and adolescents

T2 - A population based study

AU - Sriram, Swetha

AU - St. Sauver, Jennifer

AU - Jacobson, Debra J.

AU - Fan, Chun

AU - Lynch, Brian A

AU - Cristiani, Valeria

AU - Kullo, Iftikhar Jan

AU - Lteif, Aida N.

AU - Kumar, Seema

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Unfavorable lipid levels during childhood are associated with subsequent development of atherosclerotic cardiovascular disease. The American Academy of Pediatrics and National Heart, Lung and Blood Institute in 2011 recommended universal lipid screening for children between ages 9–11 years and between ages 17–21 years. The objective of the study was to determine temporal trends in lipid testing among children and young adults in a mid-western population. The Rochester Epidemiology Project database was used to identify lipid testing in ages 2–21 years (n = 51,176) in the Olmsted County population from January 1, 2008 through December 31, 2014. Generalized estimating equations with Poisson distribution were used to test for temporal trends in lipid testing across the age groups. There was modest increase in lipid testing in children in the age groups, 9–11 years and 17–21 years (1.5% in 2008 to 2.2% in 2014, P < 0.001 and 4.4% in 2008 to 4.6% in 2014, P = 0.02, respectively). There was a significant decrease in proportion of 17–21 year olds with elevated total cholesterol (16.2% in 2008 to 11.6% in 2014; P = 0.01) and non-high density lipoprotein cholesterol (22.6% in 2008 to 12.6% in 2014; P < 0.001). In this population-based study, rates of lipid testing increased minimally only in the last six years. Further longitudinal studies are warranted to improve guideline dissemination and address attitudes, practices and barriers to lipid testing in children and young adults.

AB - Unfavorable lipid levels during childhood are associated with subsequent development of atherosclerotic cardiovascular disease. The American Academy of Pediatrics and National Heart, Lung and Blood Institute in 2011 recommended universal lipid screening for children between ages 9–11 years and between ages 17–21 years. The objective of the study was to determine temporal trends in lipid testing among children and young adults in a mid-western population. The Rochester Epidemiology Project database was used to identify lipid testing in ages 2–21 years (n = 51,176) in the Olmsted County population from January 1, 2008 through December 31, 2014. Generalized estimating equations with Poisson distribution were used to test for temporal trends in lipid testing across the age groups. There was modest increase in lipid testing in children in the age groups, 9–11 years and 17–21 years (1.5% in 2008 to 2.2% in 2014, P < 0.001 and 4.4% in 2008 to 4.6% in 2014, P = 0.02, respectively). There was a significant decrease in proportion of 17–21 year olds with elevated total cholesterol (16.2% in 2008 to 11.6% in 2014; P = 0.01) and non-high density lipoprotein cholesterol (22.6% in 2008 to 12.6% in 2014; P < 0.001). In this population-based study, rates of lipid testing increased minimally only in the last six years. Further longitudinal studies are warranted to improve guideline dissemination and address attitudes, practices and barriers to lipid testing in children and young adults.

KW - Children

KW - Dyslipidemia

KW - Hypercholesterolemia

KW - Lipids

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85034852452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034852452&partnerID=8YFLogxK

U2 - 10.1016/j.pmedr.2017.11.001

DO - 10.1016/j.pmedr.2017.11.001

M3 - Article

VL - 8

SP - 267

EP - 272

JO - Preventive Medicine Reports

JF - Preventive Medicine Reports

SN - 2211-3355

ER -